DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE

DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE was reported 328 times

DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE MARROW HARVEST 1 0.1667
1 CYSTINOSIS 1 0.0476
2 SYNOVIAL SARCOMA METASTATIC 1 0.0417
3 URETERAL CATHETERISATION 1 0.0333
4 ENDOSCOPY GASTROINTESTINAL 1 0.0213
5 BLADDER IRRIGATION 1 0.0208
6 CORTICAL VISUAL IMPAIRMENT 1 0.0172
7 HYPERPARATHYROIDISM TERTIARY 1 0.0133
8 TRACHEAL INJURY 1 0.0068
9 ILIUM FRACTURE 1 0.0049
10 ADULT FAILURE TO THRIVE 1 0.0047
11 SCLERAL HAEMORRHAGE 1 0.0043
12 INCREASED NEED FOR SLEEP 1 0.0043
13 BREATHING-RELATED SLEEP DISORDER 1 0.0042
14 ADENOTONSILLECTOMY 1 0.0040
15 SCROTAL ULCER 1 0.0038
16 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
17 PITYRIASIS ROSEA 1 0.0027
18 HEPATIC INFARCTION 1 0.0027
19 METASTASES TO PANCREAS 1 0.0023
20 HERNIA PAIN 1 0.0022
21 TRANSURETHRAL PROSTATECTOMY 1 0.0020
22 HYPERPARATHYROIDISM 4 0.0019
23 RENAL TUBULAR DYSFUNCTION 1 0.0018
24 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
25 THIRST DECREASED 1 0.0016
26 PLATELET TRANSFUSION 2 0.0016
27 BORDERLINE PERSONALITY DISORDER 1 0.0014
28 VENOUS INSUFFICIENCY 1 0.0014
29 FINGER AMPUTATION 1 0.0014
30 RENAL CANCER METASTATIC 1 0.0013
31 OESOPHAGEAL PERFORATION 1 0.0012
32 PLATELET DISORDER 3 0.0012
33 PNEUMONIA KLEBSIELLA 2 0.0011
34 SKIN GRAFT 1 0.0011
35 PARTNER STRESS 1 0.0010
36 AUTONOMIC NEUROPATHY 1 0.0010
37 ABSCESS JAW 1 0.0010
38 METASTASES TO PLEURA 1 0.0010
39 NEUROGENIC BLADDER 2 0.0009
40 CORTISOL DECREASED 1 0.0009
41 RESTRICTIVE PULMONARY DISEASE 1 0.0009
42 NEPHROCALCINOSIS 1 0.0008
43 BLOOD PHOSPHORUS DECREASED 3 0.0008
44 BLOOD UREA DECREASED 1 0.0008
45 HYDRONEPHROSIS 6 0.0008
46 HYPERPARATHYROIDISM SECONDARY 2 0.0008
47 KLEBSIELLA INFECTION 4 0.0008
48 TROPONIN T INCREASED 1 0.0008
49 GLYCOSURIA 1 0.0007
50 CLONUS 2 0.0007
51 RHONCHI 1 0.0007
52 FANCONI SYNDROME 1 0.0007
53 CATAPLEXY 1 0.0007
54 DARK CIRCLES UNDER EYES 1 0.0007
55 HYPOPHOSPHATAEMIA 5 0.0007
56 SMALL CELL LUNG CANCER 1 0.0007
57 INTESTINAL OPERATION 1 0.0006
58 COLON CANCER METASTATIC 1 0.0006
59 MEDICAL PROCEDURE 1 0.0006
60 TONSILLECTOMY 1 0.0006
61 FEMALE GENITAL TRACT FISTULA 1 0.0006
62 FANCONI SYNDROME ACQUIRED 1 0.0006
63 VOCAL CORD PARALYSIS 1 0.0006
64 LIVER TRANSPLANT REJECTION 1 0.0006
65 METASTATIC RENAL CELL CARCINOMA 1 0.0005
66 UROSEPSIS 5 0.0005
67 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
68 PUPILLARY REFLEX IMPAIRED 1 0.0005
69 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
70 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
71 NASAL SEPTUM DEVIATION 1 0.0005
72 DEVICE RELATED SEPSIS 1 0.0005
73 FOAMING AT MOUTH 1 0.0005
74 DIVERTICULAR PERFORATION 1 0.0005
75 ANAEMIA MACROCYTIC 1 0.0005
76 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
77 VASCULAR DEVICE INFECTION 2 0.0004
78 PRURITUS GENITAL 1 0.0004
79 BACTERAEMIA 5 0.0004
80 EOSINOPHIL COUNT DECREASED 1 0.0004
81 WEIGHT ABNORMAL 1 0.0004
82 DERMATITIS BULLOUS 3 0.0004
83 ENTEROCOCCAL INFECTION 2 0.0004
84 LACTOSE INTOLERANCE 1 0.0004
85 DRUG TITRATION ERROR 1 0.0004
86 DECREASED ACTIVITY 4 0.0004
87 MIGRAINE WITH AURA 1 0.0004
88 BLOOD PHOSPHORUS INCREASED 1 0.0004
89 ENDOTRACHEAL INTUBATION 1 0.0004
90 HYPERTONIC BLADDER 1 0.0003
91 VOMITING PROJECTILE 1 0.0003
92 ADENOVIRUS INFECTION 1 0.0003
93 HAEMOTHORAX 1 0.0003
94 STRIDOR 1 0.0003
95 ENERGY INCREASED 2 0.0003
96 CREPITATIONS 1 0.0003
97 CHOLECYSTITIS 4 0.0003
98 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
99 NON-CARDIAC CHEST PAIN 1 0.0003
100 VULVOVAGINAL DRYNESS 1 0.0003
101 PLASMA CELL MYELOMA RECURRENT 1 0.0003
102 BACTERIAL SEPSIS 1 0.0003
103 THROMBOSIS IN DEVICE 1 0.0003
104 LISTLESS 1 0.0003
105 BLOOD CREATININE ABNORMAL 1 0.0003
106 FACIAL BONES FRACTURE 1 0.0003
107 RENAL TRANSPLANT 1 0.0003
108 CATHETER SITE INFECTION 1 0.0003
109 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
110 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
111 OBSTRUCTION 1 0.0003
112 SKIN PAPILLOMA 1 0.0002
113 SPINAL FUSION SURGERY 1 0.0002
114 NEUTROPHIL COUNT DECREASED 10 0.0002
115 PERIPHERAL VENOUS DISEASE 1 0.0002
116 SOCIAL PROBLEM 1 0.0002
117 GINGIVAL SWELLING 1 0.0002
118 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
119 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
120 DISEASE COMPLICATION 1 0.0002
121 EAR DISORDER 1 0.0002
122 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
123 SYNOVIAL CYST 1 0.0002
124 PERFORMANCE STATUS DECREASED 1 0.0002
125 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
126 NON-SMALL CELL LUNG CANCER 1 0.0002
127 ATELECTASIS 2 0.0002
128 HEPATOMEGALY 2 0.0002
129 HOSPICE CARE 2 0.0002
130 VEIN DISORDER 1 0.0002
131 POOR QUALITY DEVICE USED 2 0.0002
132 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
133 HYPOXIA 7 0.0002
134 FULL BLOOD COUNT DECREASED 4 0.0002
135 ECONOMIC PROBLEM 3 0.0002
136 TOXIC ENCEPHALOPATHY 1 0.0002
137 WEIGHT LOSS POOR 1 0.0002
138 PHLEBITIS 1 0.0002
139 PERIORBITAL OEDEMA 1 0.0002
140 ANHEDONIA 5 0.0002
141 INJECTION SITE DISCHARGE 1 0.0002
142 BLOOD POTASSIUM INCREASED 3 0.0002
143 ASPIRATION 2 0.0002
144 HYPERKERATOSIS 1 0.0002
145 NEUROLOGICAL SYMPTOM 1 0.0002
146 ELECTROLYTE IMBALANCE 2 0.0002
147 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
148 COVID-19 PNEUMONIA 2 0.0002
149 BLOOD IRON DECREASED 2 0.0002
150 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
151 PLATELET COUNT ABNORMAL 1 0.0002
152 END STAGE RENAL DISEASE 3 0.0002
153 DERMATITIS ACNEIFORM 1 0.0002
154 PRE-EXISTING CONDITION IMPROVED 1 0.0002
155 INCOHERENT 1 0.0002
156 HERPES SIMPLEX 1 0.0002
157 ANGINA UNSTABLE 1 0.0002
158 PLASMA CELL MYELOMA 6 0.0002
159 PLATELET COUNT INCREASED 2 0.0002
160 POLYP 1 0.0002
161 SOMNAMBULISM 1 0.0002
162 PULMONARY CONGESTION 2 0.0002
163 HAEMATOCRIT DECREASED 3 0.0002
164 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
165 APPETITE DISORDER 1 0.0002
166 URINARY RETENTION 5 0.0001
167 SKIN MASS 1 0.0001
168 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
169 TASTE DISORDER 3 0.0001
170 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
171 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
172 EYE MOVEMENT DISORDER 1 0.0001
173 LYMPHOEDEMA 1 0.0001
174 APHONIA 2 0.0001
175 GRAFT VERSUS HOST DISEASE 1 0.0001
176 MYELODYSPLASTIC SYNDROME 2 0.0001
177 MAJOR DEPRESSION 1 0.0001
178 LABORATORY TEST ABNORMAL 4 0.0001
179 CARDIOMYOPATHY 2 0.0001
180 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
181 BREAST TENDERNESS 1 0.0001
182 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
183 RENAL FAILURE CHRONIC 1 0.0001
184 HYPOALBUMINAEMIA 1 0.0001
185 APNOEA 1 0.0001
186 RESPIRATORY TRACT CONGESTION 2 0.0001
187 ULCER 2 0.0001
188 SCIATICA 2 0.0001
189 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
190 TRANSPLANT REJECTION 1 0.0001
191 POST PROCEDURAL INFECTION 1 0.0001
192 DECUBITUS ULCER 1 0.0001
193 ABNORMAL FAECES 1 0.0001
194 SPINAL COMPRESSION FRACTURE 1 0.0001
195 FEBRILE NEUTROPENIA 8 0.0001
196 SECOND PRIMARY MALIGNANCY 1 0.0001
197 HYPOPHAGIA 3 0.0001
198 SKIN HYPERPIGMENTATION 1 0.0001
199 METASTASES TO LIVER 2 0.0001
200 HEAD DISCOMFORT 2 0.0001
201 DEVELOPMENTAL DELAY 1 0.0001
202 OROPHARYNGEAL DISCOMFORT 1 0.0001
203 PNEUMONIA BACTERIAL 1 0.0001
204 RETINAL DETACHMENT 1 0.0001
205 IRON DEFICIENCY ANAEMIA 1 0.0001
206 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
207 PRODUCT DISTRIBUTION ISSUE 1 0.0001
208 HEPATIC STEATOSIS 2 0.0001
209 NEPHROPATHY 1 0.0001
210 APPENDICITIS 1 0.0001
211 LEUKAEMIA 1 0.0001
212 RECALLED PRODUCT ADMINISTERED 1 0.0001
213 SALIVARY HYPERSECRETION 1 0.0001
214 POOR VENOUS ACCESS 1 0.0001
215 INCONTINENCE 1 0.0001
216 BODY HEIGHT DECREASED 1 0.0001
217 SKIN CANCER 2 0.0001
218 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
219 DEHYDRATION 12 0.0001
220 TRANSAMINASES INCREASED 2 0.0001
221 TOOTH DISORDER 2 0.0001
222 NERVE INJURY 1 0.0001
223 FISTULA 1 0.0001
224 STATUS EPILEPTICUS 1 0.0001
225 PRODUCT AVAILABILITY ISSUE 2 0.0001
226 INTERNAL HAEMORRHAGE 1 0.0001
227 MYOCARDITIS 1 0.0001
228 LETHARGY 5 0.0001
229 SPINAL PAIN 1 0.0001
230 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
231 HYPERLIPIDAEMIA 1 0.0001
232 BLOOD PRESSURE FLUCTUATION 2 0.0001
233 RESPIRATORY DEPRESSION 1 0.0001
234 CARDIOMEGALY 1 0.0001
235 SMALL INTESTINAL OBSTRUCTION 1 0.0001
236 OSTEONECROSIS OF JAW 2 0.0001
237 SEPSIS 9 0.0001
238 DERMATITIS ALLERGIC 1 0.0001
239 COLITIS 3 0.0001
240 HAEMOGLOBIN DECREASED 8 0.0001
241 SKIN ULCER 2 0.0001
242 BLOOD CREATININE INCREASED 5 0.0001
243 BEDRIDDEN 1 0.0001
244 GASTRITIS 2 0.0001
245 IMMUNE SYSTEM DISORDER 1 0.0001
246 PLATELET COUNT DECREASED 8 0.0001
247 QUALITY OF LIFE DECREASED 1 0.0001
248 HYPOMAGNESAEMIA 1 0.0001
249 COORDINATION ABNORMAL 1 0.0001
250 DEVICE OCCLUSION 1 0.0001
251 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
252 LYMPHOPENIA 1 0.0001
253 RED BLOOD CELL COUNT DECREASED 2 0.0001
254 PARAESTHESIA ORAL 1 0.0001
255 GASTROENTERITIS 1 0.0001
256 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
257 BONE PAIN 4 0.0001
258 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
259 PULMONARY MASS 1 0.0001
260 IMMUNODEFICIENCY 1 0.0001
261 PULMONARY OEDEMA 3 0.0001
262 RESPIRATORY DISORDER 2 0.0001
263 BONE LOSS 1 0.0001
264 BLOOD POTASSIUM DECREASED 2 0.0001
265 BLOOD COUNT ABNORMAL 1 0.0001
266 OSTEOPENIA 1 0.0001
267 CHRONIC KIDNEY DISEASE 5 0.0001
268 HYPOKALAEMIA 3 0.0001
269 DEVICE RELATED INFECTION 1 0.0001
270 LYMPHOMA 1 0.0001
271 LUNG INFECTION 1 0.0001
272 EJECTION FRACTION DECREASED 1 0.0001
273 BASAL CELL CARCINOMA 1 0.0001
274 BRAIN FOG 1 0.0001
275 PRODUCT USE COMPLAINT 1 0.0001
276 HEAD INJURY 2 0.0001
277 NEUROPATHY PERIPHERAL 6 0.0001
278 CYSTITIS 2 0.0001
279 MUSCLE TIGHTNESS 1 0.0001
280 BACK DISORDER 1 0.0001
281 METASTASES TO BONE 1 0.0001
282 CYTOMEGALOVIRUS INFECTION 1 0.0001
283 VIRAL INFECTION 2 0.0001
284 BLOOD UREA INCREASED 1 0.0001
285 TYPE 2 DIABETES MELLITUS 2 0.0001
286 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
287 CANDIDA INFECTION 1 0.0001
288 NEOPLASM PROGRESSION 2 0.0001
289 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
290 OEDEMA PERIPHERAL 7 0.0001
291 ORTHOSTATIC HYPOTENSION 1 0.0001
292 DECREASED APPETITE 13 0.0001
293 BONE DISORDER 1 0.0001
294 DYSURIA 2 0.0001
295 BRONCHITIS 4 0.0001
296 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
297 PHOTOPHOBIA 1 0.0001
298 BLOOD SODIUM DECREASED 1 0.0001
299 HYPOCALCAEMIA 1 0.0001
300 FRACTURE 1 0.0001
301 PROTEINURIA 1 0.0001
302 ACUTE KIDNEY INJURY 8 0.0001
303 PULMONARY FIBROSIS 1 0.0001
304 DRUG PRESCRIBING ERROR 1 0.0001
305 ACUTE RESPIRATORY FAILURE 1 0.0001
306 HERNIA 1 0.0001
307 DYSPHONIA 3 0.0001
308 ORAL HERPES 1 0.0001
309 SKIN FISSURES 1 0.0001
310 KIDNEY INFECTION 1 0.0001
311 BLOOD PRESSURE ABNORMAL 1 0.0001
312 CYTOKINE RELEASE SYNDROME 1 0.0000
313 PRODUCT PHYSICAL ISSUE 1 0.0000
314 EMOTIONAL DISTRESS 6 0.0000
315 OSTEOPOROSIS 2 0.0000
316 RIB FRACTURE 1 0.0000
317 TOOTH LOSS 1 0.0000
318 ABDOMINAL DISTENSION 5 0.0000
319 DERMATITIS 1 0.0000
320 ANAEMIA 9 0.0000
321 IMPAIRED WORK ABILITY 1 0.0000
322 IRRITABLE BOWEL SYNDROME 1 0.0000
323 LIVER FUNCTION TEST INCREASED 1 0.0000
324 POOR QUALITY SLEEP 1 0.0000
325 PNEUMONIA 15 0.0000
326 PRURITUS GENERALISED 1 0.0000
327 PRODUCT PRESCRIBING ISSUE 1 0.0000
328 STEVENS-JOHNSON SYNDROME 1 0.0000
329 PRODUCT DOSE OMISSION ISSUE 13 0.0000
330 NEPHROLITHIASIS 2 0.0000
331 SKIN DISCOLOURATION 2 0.0000
332 SEIZURE 5 0.0000
333 PERICARDIAL EFFUSION 1 0.0000
334 OROPHARYNGEAL PAIN 4 0.0000
335 ASTHENIA 16 0.0000
336 HYPERTENSION 9 0.0000
337 DISEASE PROGRESSION 5 0.0000
338 PRODUCTIVE COUGH 2 0.0000
339 ABDOMINAL DISCOMFORT 7 0.0000
340 BLOOD GLUCOSE DECREASED 2 0.0000
341 NEURALGIA 1 0.0000
342 DYSGEUSIA 3 0.0000
343 AGEUSIA 1 0.0000
344 PNEUMONIA ASPIRATION 1 0.0000
345 COVID-19 7 0.0000
346 CELLULITIS 2 0.0000
347 UNEVALUABLE EVENT 3 0.0000
348 HOSPITALISATION 6 0.0000
349 RASH GENERALISED 1 0.0000
350 DIPLOPIA 1 0.0000
351 DEAFNESS 1 0.0000
352 PANCREATITIS 2 0.0000
353 RENAL FAILURE 5 0.0000
354 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
355 EAR INFECTION 1 0.0000
356 JAUNDICE 1 0.0000
357 FREQUENT BOWEL MOVEMENTS 1 0.0000
358 LIMB INJURY 1 0.0000
359 PNEUMONITIS 1 0.0000
360 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
361 INFLUENZA LIKE ILLNESS 3 0.0000
362 RESPIRATORY DISTRESS 1 0.0000
363 DIVERTICULITIS 1 0.0000
364 MENTAL STATUS CHANGES 1 0.0000
365 ARTHROPATHY 2 0.0000
366 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
367 HAEMOPTYSIS 1 0.0000
368 DEMENTIA 1 0.0000
369 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
370 ANGINA PECTORIS 1 0.0000
371 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
372 FATIGUE 27 0.0000
373 NEEDLE ISSUE 1 0.0000
374 ASCITES 1 0.0000
375 ACUTE MYOCARDIAL INFARCTION 1 0.0000
376 CATARACT 2 0.0000
377 ADVERSE DRUG REACTION 3 0.0000
378 FALL 11 0.0000
379 STOMATITIS 2 0.0000
380 DISCOMFORT 2 0.0000
381 LIMB DISCOMFORT 1 0.0000
382 SWOLLEN TONGUE 1 0.0000
383 BONE DENSITY DECREASED 1 0.0000
384 ANXIETY 9 0.0000
385 MOOD SWINGS 1 0.0000
386 MOVEMENT DISORDER 1 0.0000
387 DRUG INTOLERANCE 3 0.0000
388 DEEP VEIN THROMBOSIS 2 0.0000
389 SWELLING FACE 2 0.0000
390 PRODUCT DOSE OMISSION 2 0.0000
391 CHOLELITHIASIS 1 0.0000
392 STAPHYLOCOCCAL INFECTION 1 0.0000
393 SOMNOLENCE 6 0.0000
394 URINARY TRACT INFECTION 5 0.0000
395 SINUSITIS 3 0.0000
396 GASTRIC DISORDER 1 0.0000
397 VISION BLURRED 4 0.0000
398 WEIGHT DECREASED 8 0.0000
399 HYPERKALAEMIA 1 0.0000
400 LYMPHADENOPATHY 1 0.0000
401 DIARRHOEA 18 0.0000
402 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
403 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
404 CONSTIPATION 6 0.0000
405 HYPERGLYCAEMIA 1 0.0000
406 BLOOD PRESSURE INCREASED 4 0.0000
407 OFF LABEL USE 22 0.0000
408 FEELING ABNORMAL 6 0.0000
409 CARDIAC FAILURE 2 0.0000
410 THROMBOSIS 2 0.0000
411 EXTRA DOSE ADMINISTERED 1 0.0000
412 BLINDNESS 1 0.0000
413 CARDIAC ARREST 2 0.0000
414 CARDIO-RESPIRATORY ARREST 1 0.0000
415 PAIN IN EXTREMITY 7 0.0000
416 OSTEOARTHRITIS 1 0.0000
417 RENAL FAILURE ACUTE 1 0.0000
418 LOSS OF CONSCIOUSNESS 3 0.0000
419 RECTAL HAEMORRHAGE 1 0.0000
420 DEATH 20 0.0000
421 BALANCE DISORDER 2 0.0000
422 PYREXIA 8 0.0000
423 MUSCULOSKELETAL STIFFNESS 2 0.0000
424 TACHYCARDIA 2 0.0000
425 DRY SKIN 3 0.0000
426 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
427 GASTROINTESTINAL DISORDER 2 0.0000
428 DEVICE ISSUE 2 0.0000
429 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
430 NEUTROPENIA 3 0.0000
431 MUSCLE SPASMS 4 0.0000
432 NASOPHARYNGITIS 4 0.0000
433 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
434 NAUSEA 17 0.0000
435 RENAL DISORDER 1 0.0000
436 BLOOD CHOLESTEROL INCREASED 1 0.0000
437 VOMITING 10 0.0000
438 PAIN 13 0.0000
439 DYSPHAGIA 2 0.0000
440 PULMONARY EMBOLISM 2 0.0000
441 RENAL CANCER 1 0.0000
442 RASH ERYTHEMATOUS 1 0.0000
443 CONTUSION 2 0.0000
444 INFECTION 3 0.0000
445 HYPOGLYCAEMIA 1 0.0000
446 ATRIAL FIBRILLATION 2 0.0000
447 ALOPECIA 4 0.0000
448 HYPOAESTHESIA 3 0.0000
449 DRY EYE 1 0.0000
450 LEUKOPENIA 1 0.0000
451 SYNCOPE 2 0.0000
452 FLUID RETENTION 1 0.0000
453 CHEST DISCOMFORT 2 0.0000
454 ILLNESS 2 0.0000
455 INFLAMMATION 1 0.0000
456 HAEMORRHAGE 2 0.0000
457 PARAESTHESIA 3 0.0000
458 DRUG EFFECT DECREASED 1 0.0000
459 CONFUSIONAL STATE 3 0.0000
460 DRUG DOSE OMISSION 3 0.0000
461 ANAPHYLACTIC REACTION 1 0.0000
462 THROMBOCYTOPENIA 2 0.0000
463 BLISTER 1 0.0000
464 OXYGEN SATURATION DECREASED 1 0.0000
465 HYPONATRAEMIA 1 0.0000
466 ASTHMA 2 0.0000
467 DYSPNOEA 10 0.0000
468 MYALGIA 3 0.0000
469 FLATULENCE 1 0.0000
470 MUSCULAR WEAKNESS 2 0.0000
471 HEADACHE 11 0.0000
472 INCORRECT DOSE ADMINISTERED 4 0.0000
473 HERPES ZOSTER 1 0.0000
474 EYE IRRITATION 1 0.0000
475 CHILLS 2 0.0000
476 ARTHRALGIA 7 0.0000
477 THERAPEUTIC RESPONSE DECREASED 1 0.0000
478 CONDITION AGGRAVATED 5 0.0000
479 PLEURAL EFFUSION 1 0.0000
480 VERTIGO 1 0.0000
481 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
482 RASH 7 0.0000
483 DIZZINESS 8 0.0000
484 PRODUCT USE ISSUE 3 0.0000
485 BLOOD GLUCOSE INCREASED 3 0.0000
486 GAIT DISTURBANCE 3 0.0000
487 HYPERHIDROSIS 2 0.0000
488 AMNESIA 1 0.0000
489 BLOOD PRESSURE DECREASED 1 0.0000
490 INSOMNIA 4 0.0000
491 NEOPLASM MALIGNANT 1 0.0000
492 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
493 HEPATIC ENZYME INCREASED 1 0.0000
494 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
495 BURNING SENSATION 1 0.0000
496 INJURY 1 0.0000
497 SLEEP DISORDER 1 0.0000
498 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
499 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
500 THERAPY INTERRUPTED 1 0.0000
501 RESPIRATORY FAILURE 1 0.0000
502 UNDERDOSE 1 0.0000
503 MALAISE 6 0.0000
504 EPISTAXIS 1 0.0000
505 HALLUCINATION 1 0.0000
506 HOT FLUSH 1 0.0000
507 DEPRESSION 3 0.0000
508 DIABETES MELLITUS 1 0.0000
509 INJECTION SITE SWELLING 1 0.0000
510 PERIPHERAL SWELLING 2 0.0000
511 ABDOMINAL PAIN 3 0.0000
512 DRUG DOSE OMISSION BY DEVICE 1 0.0000
513 ARTHRITIS 1 0.0000
514 INJECTION SITE BRUISING 1 0.0000
515 CARDIAC FAILURE CONGESTIVE 1 0.0000
516 DRY MOUTH 1 0.0000
517 TREMOR 2 0.0000
518 URTICARIA 2 0.0000
519 RENAL IMPAIRMENT 1 0.0000
520 SKIN EXFOLIATION 1 0.0000
521 PRODUCT STORAGE ERROR 1 0.0000
522 INTENTIONAL PRODUCT MISUSE 1 0.0000
523 CHEST PAIN 2 0.0000
524 BREAST CANCER 1 0.0000
525 HYPOTENSION 2 0.0000
526 FLUSHING 1 0.0000
527 DRUG INEFFECTIVE 12 0.0000
528 BACK PAIN 2 0.0000
529 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
530 PRURITUS 3 0.0000
531 MEMORY IMPAIRMENT 1 0.0000
532 COUGH 2 0.0000
533 HYPERSENSITIVITY 1 0.0000
534 OVERDOSE 1 0.0000
535 INJECTION SITE PAIN 1 0.0000